138 related articles for article (PubMed ID: 29868484)
1. Development of a Human Leukocyte Antigen Score to Predict Progression-Free Survival in Head and Neck Squamous Cell Carcinoma Patients.
Wichmann G; Lehmann C; Herchenhahn C; Kolb M; Hofer M; Wiegand S; Dietz A
Front Oncol; 2018; 8():168. PubMed ID: 29868484
[TBL] [Abstract][Full Text] [Related]
2. HLA traits linked to development of head and neck squamous cell carcinoma affect the progression-free survival of patients.
Wichmann G; Herchenhahn C; Boehm A; Mozet C; Hofer M; Fischer M; Kolb M; Dietz A
Oral Oncol; 2017 Jun; 69():115-127. PubMed ID: 28559015
[TBL] [Abstract][Full Text] [Related]
3. Outcome differences in HPV-driven head and neck squamous cell carcinoma attributable to altered human leukocyte antigen frequencies.
Wichmann G; Vetter N; Lehmann C; Landgraf R; Doxiadis I; Großmann R; Vorobeva E; Dietz A; Zebralla V; Wiegand S; Wald T
Front Oncol; 2023; 13():1212454. PubMed ID: 38192630
[TBL] [Abstract][Full Text] [Related]
4. Pre-Therapeutic VEGF Level in Plasma Is a Prognostic Bio-Marker in Head and Neck Squamous Cell Carcinoma (HNSCC).
Siemert J; Wald T; Kolb M; Pettinella I; Böhm U; Pirlich M; Wiegand S; Dietz A; Wichmann G
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359680
[TBL] [Abstract][Full Text] [Related]
5. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
[TBL] [Abstract][Full Text] [Related]
6. Discrimination of Head and Neck Squamous Cell Carcinoma Patients and Healthy Adults by 10-Color Flow Cytometry: Development of a Score Based on Leukocyte Subsets.
Wichmann G; Gaede C; Melzer S; Bocsi J; Henger S; Engel C; Wirkner K; Wenning JR; Wald T; Freitag J; Willner M; Kolb M; Wiegand S; Löffler M; Dietz A; Tárnok A
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31212819
[TBL] [Abstract][Full Text] [Related]
7. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
[TBL] [Abstract][Full Text] [Related]
8. Head and neck PET/CT: therapy response interpretation criteria (Hopkins Criteria)-interreader reliability, accuracy, and survival outcomes.
Marcus C; Ciarallo A; Tahari AK; Mena E; Koch W; Wahl RL; Kiess AP; Kang H; Subramaniam RM
J Nucl Med; 2014 Sep; 55(9):1411-6. PubMed ID: 24947059
[TBL] [Abstract][Full Text] [Related]
9. Human Leucocyte Antigens as Prognostic Markers in Head and Neck Squamous Cell Carcinoma.
Dyckhoff G; Herold-Mende C; Scherer S; Plinkert PK; Warta R
Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954492
[TBL] [Abstract][Full Text] [Related]
10. Phase III randomized trial of preoperative concurrent chemoradiotherapy versus preoperative radiotherapy for patients with locally advanced head and neck squamous cell carcinoma.
Yi J; Huang X; Xu Z; Liu S; Wang X; He X; Luo D; Luo J; Xiao J; Zhang S; Wang K; Qu Y; Tang Y; Liu W; Xu G; Gao L; Wang D
Oncotarget; 2017 Jul; 8(27):44842-44850. PubMed ID: 28179586
[TBL] [Abstract][Full Text] [Related]
11. HLA and MICA associations with head and neck squamous cell carcinoma.
Reinders J; Rozemuller EH; Otten HG; van der Veken LT; Slootweg PJ; Tilanus MG
Oral Oncol; 2007 Mar; 43(3):232-40. PubMed ID: 16857416
[TBL] [Abstract][Full Text] [Related]
12. Temporalis muscle thickness as an indicator of sarcopenia predicts progression-free survival in head and neck squamous cell carcinoma.
Lee B; Bae YJ; Jeong WJ; Kim H; Choi BS; Kim JH
Sci Rep; 2021 Oct; 11(1):19717. PubMed ID: 34611230
[TBL] [Abstract][Full Text] [Related]
13. Cell surface markers for T and B lymphocytes activation and adhesion as putative prognostic biomarkers for head and neck squamous cell carcinoma.
Andrade MC; Ferreira SB; Gonçalves LC; De-Paula AM; de Faria ES; Teixeira-Carvalho A; Martins-Filho OA
Hum Immunol; 2013 Dec; 74(12):1563-74. PubMed ID: 23994583
[TBL] [Abstract][Full Text] [Related]
14. Using high-resolution human leukocyte antigen typing of 11,423 randomized unrelated individuals to determine allelic varieties, deduce probable human leukocyte antigen haplotypes, and observe linkage disequilibria between human leukocyte antigen-B and-C and human leukocyte antigen-DRB1 and-DQB1 alleles in the Taiwanese Chinese population.
Yang KL; Chen HB
Ci Ji Yi Xue Za Zhi; 2017; 29(2):84-90. PubMed ID: 28757772
[TBL] [Abstract][Full Text] [Related]
15. Circulating Tumor Cells Correlate With Prognosis in Head and Neck Squamous Cell Carcinoma.
Zhou S; Wang L; Zhang W; Liu F; Zhang Y; Jiang B; Wang J; Yuan H
Technol Cancer Res Treat; 2021; 20():1533033821990037. PubMed ID: 33641530
[TBL] [Abstract][Full Text] [Related]
16. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.
Meissner M; Reichert TE; Kunkel M; Gooding W; Whiteside TL; Ferrone S; Seliger B
Clin Cancer Res; 2005 Apr; 11(7):2552-60. PubMed ID: 15814633
[TBL] [Abstract][Full Text] [Related]
17. Identification and Validation of a Novel Genomic Instability-Associated Long Non-Coding RNA Prognostic Signature in Head and Neck Squamous Cell Carcinoma.
Chen Y; Zhao Y; Lu R; Zhao H; Guo Y
Front Cell Dev Biol; 2021; 9():787766. PubMed ID: 35127708
[No Abstract] [Full Text] [Related]
18. Hypoxia dynamics on FMISO-PET in combination with PD-1/PD-L1 expression has an impact on the clinical outcome of patients with Head-and-neck Squamous Cell Carcinoma undergoing Chemoradiation.
Rühle A; Grosu AL; Wiedenmann N; Mix M; Stoian R; Niedermann G; Baltas D; Werner M; Weber WA; Kayser G; Nicolay NH
Theranostics; 2020; 10(20):9395-9406. PubMed ID: 32802199
[TBL] [Abstract][Full Text] [Related]
19.
Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; Franzen A; Dietrich J; Kristiansen G; Bootz F; Schröck A; Dietrich D
Clin Epigenetics; 2017; 9():12. PubMed ID: 28174607
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact and potential predictive role of baseline circulating tumor cells in locally advanced head and neck squamous cell carcinoma.
Bueno de Oliveira T; Camila Braun A; Ribaldo Nicolau U; Ali Abdallah E; da Silva Alves V; Hugo Fonseca de Jesus V; Fernando Calsavara V; Paulo Kowaslki L; Domingos Chinen LT
Oral Oncol; 2021 Oct; 121():105480. PubMed ID: 34403888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]